[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Peptide Antibiotics Market Size study, by Product Type (Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics), By Disease (Skin Infection, HABP/VABP, Blood Stream Infection, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2028

August 2022 | 200 pages | ID: G65C97C30CBDEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Peptide Antibiotics Market is valued approximately USD 4.37 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2022-2028. The factors driving market expansion include rising demand for peptide antibiotics in hospitals and clinics, as well as an increase in the occurrence of illnesses such as bacterial skin infections, bloodstream infections, and hospital acquired infections. Furthermore, growing product approvals and product launches are likely to drive growth during the projection period. The market for peptide antibiotics is predicted to expand due to the increased frequency of central line-associated blood stream infections. According to the Australian Institute of Health and Welfare, During 2019-2020, 700 Australian public hospitals reported 1,428 instances of Staphylococcus aureus blood stream infections,. Rising demand for peptide antibiotics in hospitals and clinics, as well as an increase in the prevalence of ailments such as bacterial skin infections, bloodstream infections, and hospital acquired infections, are driving market expansion. Furthermore, rising product approvals and launches are expected to boost growth during the forecast period. Because of the increased prevalence of central line-associated blood stream infections, the market for peptide antibiotics is expected to grow. According to the Australian Institute of Health and Welfare, 700 Australian public hospitals reported 1,428 cases of Staphylococcus aureus blood stream infections in 2019-2020. Furthermore, the CDC is sponsoring programmes that help over 50 state health departments and several municipal health departments through the CDC's Antimicrobial Resistance Initiative. The CDC has also worked with state and local health departments, federal agencies, and the commercial sector to reduce the threat of antibiotic resistance. The high cost of Peptide Antibiotics, on the other hand, stifles market growth from 2022 to 2028.

The key regions considered for the Global Peptide Antibiotics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the peptide antibiotics market, followed by Europe. Some of the significant reasons driving development include the existence of a large number of market participants and strategic efforts implemented by prominent players. Furthermore, increased antibiotic demand in this area, as well as a rise in R&D activities in the region, are likely to boost the market throughout the projection period. Due to reasons like as increased frequency of different infectious illnesses, expanding elderly population, and increased patient knowledge about their health, Asia Pacific is predicted to be the fastest growing region throughout the forecast period.

Major market player included in this report are:
Pfizer Inc.
Merck & Co., Inc.
AbbVie Inc
GSK Group of Companies
Sandoz International GmbH
Xellia Pharmaceuticals
AuroMedics Pharma LLC
Theravance Biopharma
Teva Pharmaceutical Industries Ltd
Sanofi
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomal Synthesized Peptide Antibiotics
By Disease;
Skin Infection
HABP/VABP
Blood Stream Infection
Others
By Route Of Administration
Oral
Injectable
Topical
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Peptide Antibiotics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  1.2.1. Peptide Antibiotics Market, by Region, 2020-2028 (USD Billion)
  1.2.2. Peptide Antibiotics Market, by Product Type, 2020-2028 (USD Billion)
  1.2.3. Peptide Antibiotics Market, by Disease, 2020-2028 (USD Billion)
  1.2.4. Peptide Antibiotics Market, by Route of Administration, 2020-2028 (USD Billion)
  1.2.5. Peptide Antibiotics Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL PEPTIDE ANTIBIOTICS MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL PEPTIDE ANTIBIOTICS MARKET DYNAMICS

3.1. Peptide Antibiotics Market Impact Analysis (2020-2028)
  3.1.1. Market Drivers
    3.1.1.1. Increasing prevalence of diseases such as, bacterial skin infections, blood stream infections, and hospital acquired infections
    3.1.1.2. Increasing demand of peptide antibiotics in hospitals and clinics
  3.1.2. Market Challenges
    3.1.2.1. High Cost of Peptide Antibiotics
  3.1.3. Market Opportunities
    3.1.3.1. Advancements in Formulation
    3.1.3.2. Surge in prevalence of blood stream infections

CHAPTER 4. GLOBAL PEPTIDE ANTIBIOTICS MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

  5.1.1. Assessment of the overall impact of COVID-19 on the industry
  5.1.2. Pre COVID-19 and post COVID-19 Market scenario

CHAPTER 6. GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY PRODUCT TYPE

6.1. Market Snapshot
6.2. Global Peptide Antibiotics Market by Product Type, Performance - Potential Analysis
6.3. Global Peptide Antibiotics Market Estimates & Forecasts by Product Type 2018-2028 (USD Billion)
6.4. Peptide Antibiotics Market, Sub Segment Analysis
  6.4.1. Ribosomal Synthesized Peptide Antibiotics
  6.4.2. Non-Ribosomal Synthesized Peptide Antibiotics

CHAPTER 7. GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY DISEASE

7.1. Market Snapshot
7.2. Global Peptide Antibiotics Market by Disease, Performance - Potential Analysis
7.3. Global Peptide Antibiotics Market Estimates & Forecasts by Disease 2018-2028 (USD Billion)
7.4. Peptide Antibiotics Market, Sub Segment Analysis
  7.4.1. Skin Infection
  7.4.2. HABP/VABP
  7.4.3. Blood Stream Infection
  7.4.4. Others

CHAPTER 8. GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY ROUTE OF ADMINISTRATION

8.1. Market Snapshot
8.2. Global Peptide Antibiotics Market by Route of Administration, Performance - Potential Analysis
8.3. Global Peptide Antibiotics Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Billion)
8.4. Peptide Antibiotics Market, Sub Segment Analysis
  8.4.1. Oral
  8.4.2. Injectable
  8.4.3. Topical
  8.4.4. Others

CHAPTER 9. GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY DISTRIBUTION CHANNEL

9.1. Market Snapshot
9.2. Global Peptide Antibiotics Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Peptide Antibiotics Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
9.4. Peptide Antibiotics Market, Sub Segment Analysis
  9.4.1. Hospital Pharmacies
  9.4.2. Retail Pharmacies
  9.4.3. Online Pharmacies

CHAPTER 10. GLOBAL PEPTIDE ANTIBIOTICS MARKET, REGIONAL ANALYSIS

10.1. Peptide Antibiotics Market, Regional Market Snapshot
10.2. North America Peptide Antibiotics Market
  10.2.1. U.S. Peptide Antibiotics Market
    10.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
    10.2.1.2. Disease breakdown estimates & forecasts, 2018-2028
    10.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2028
    10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2028
  10.2.2. Canada Peptide Antibiotics Market
10.3. Europe Peptide Antibiotics Market Snapshot
  10.3.1. U.K. Peptide Antibiotics Market
  10.3.2. Germany Peptide Antibiotics Market
  10.3.3. France Peptide Antibiotics Market
  10.3.4. Spain Peptide Antibiotics Market
  10.3.5. Italy Peptide Antibiotics Market
  10.3.6. Rest of Europe Peptide Antibiotics Market
10.4. Asia-Pacific Peptide Antibiotics Market Snapshot
  10.4.1. China Peptide Antibiotics Market
  10.4.2. India Peptide Antibiotics Market
  10.4.3. Japan Peptide Antibiotics Market
  10.4.4. Australia Peptide Antibiotics Market
  10.4.5. South Korea Peptide Antibiotics Market
  10.4.6. Rest of Asia Pacific Peptide Antibiotics Market
10.5. Latin America Peptide Antibiotics Market Snapshot
  10.5.1. Brazil Peptide Antibiotics Market
  10.5.2. Mexico Peptide Antibiotics Market
10.6. Rest of The World Peptide Antibiotics Market

CHAPTER 11. COMPETITIVE INTELLIGENCE

11.1. Top Market Strategies
11.2. Company Profiles
  11.2.1. Pfizer Inc.
    11.2.1.1. Key Information
    11.2.1.2. Overview
    11.2.1.3. Financial (Subject to Data Availability)
    11.2.1.4. Product Summary
    11.2.1.5. Recent Developments
  11.2.2. Merck & Co., Inc.
  11.2.3. AbbVie Inc
  11.2.4. GSK Group of Companies
  11.2.5. Sandoz International GmbH
  11.2.6. Xellia Pharmaceuticals
  11.2.7. AuroMedics Pharma LLC
  11.2.8. Theravance Biopharma
  11.2.9. Teva Pharmaceutical Industries Ltd
  11.2.10. Sanofi

CHAPTER 12. RESEARCH PROCESS

12.1. Research Process
  12.1.1. Data Mining
  12.1.2. Analysis
  12.1.3. Market Estimation
  12.1.4. Validation
  12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Peptide Antibiotics Market, report scope
TABLE 2. Global Peptide Antibiotics Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Peptide Antibiotics Market estimates & forecasts by Product Type 2018-2028 (USD Billion)
TABLE 4. Global Peptide Antibiotics Market estimates & forecasts by Disease 2018-2028 (USD Billion)
TABLE 5. Global Peptide Antibiotics Market estimates & forecasts by Route of Administration 2018-2028 (USD Billion)
TABLE 6. Global Peptide Antibiotics Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
TABLE 7. Global Peptide Antibiotics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Peptide Antibiotics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Peptide Antibiotics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Peptide Antibiotics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Peptide Antibiotics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Peptide Antibiotics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Peptide Antibiotics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Peptide Antibiotics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Peptide Antibiotics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. Global Peptide Antibiotics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 18. U.S. Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. U.S. Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 20. Canada Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 21. Canada Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. Canada Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 23. UK Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 24. UK Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. UK Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 26. Germany Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 27. Germany Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. Germany Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 29. RoE Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 30. RoE Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. RoE Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 32. China Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 33. China Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. China Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 35. India Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 36. India Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. India Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 38. Japan Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 39. Japan Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. Japan Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 41. RoAPAC Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 42. RoAPAC Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. RoAPAC Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 44. Brazil Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 45. Brazil Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Brazil Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 47. Mexico Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 48. Mexico Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. Mexico Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 50. RoLA Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 51. RoLA Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. RoLA Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 53. Row Peptide Antibiotics Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 54. Row Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. Row Peptide Antibiotics Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Peptide Antibiotics Market
TABLE 57. List of primary sources, used in the study of global Peptide Antibiotics Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Peptide Antibiotics Market, research methodology
FIG 2. Global Peptide Antibiotics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Peptide Antibiotics Market, key trends 2021
FIG 5. Global Peptide Antibiotics Market, growth prospects 2022-2028
FIG 6. Global Peptide Antibiotics Market, porters 5 force model
FIG 7. Global Peptide Antibiotics Market, pest analysis
FIG 8. Global Peptide Antibiotics Market, value chain analysis
FIG 9. Global Peptide Antibiotics Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Peptide Antibiotics Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Peptide Antibiotics Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Peptide Antibiotics Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Peptide Antibiotics Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Peptide Antibiotics Market, regional snapshot 2018 & 2028
FIG 15. North America Peptide Antibiotics Market 2018 & 2028 (USD Billion)
FIG 16. Europe Peptide Antibiotics Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Peptide Antibiotics Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Peptide Antibiotics Market 2018 & 2028 (USD Billion)
FIG 19. Global Peptide Antibiotics Market, company Market share analysis (2021)

















More Publications